Skip to content

Prognostic value of systemic inflammation score in patients with esophageal cancer

Prognostic value of systemic inflammation score in patients with esophageal cancer - Prognostic value of systemic inflammation score in patients with esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053166
Enrollment
32
Registered
2023-12-20
Start date
2019-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Sponsors

NHO Nagasaki Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This retrospective cohort study included 32 patients who underwent thoracoscopic esophagectomy after neoadjuvant chemotherapy for esophageal cancer at the Department of Surgery of the Nagasaki Medical Center (Omura, Japan) between January 2016 and December 2019.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The association with recurrence and SIS.

Countries

Japan

Contacts

Public ContactAkira Yoneda

NHO Nagasaki Medical Center Department of Surgery

akira-br@infoseek.jp+81-957-52-3121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026